Autoimmune mechanisms in pulmonary arterial hypertension
10 July 2024
A PVRI 2024 Digital webinar
10 July 2024, 3PM BST
Presentations
- Autoantibodies as the cause of pulmonary arterial hypertension, Mark Toshner, University of Cambridge, UK
- Prevalence and effect of myelofibrosis on pulmonary arterial hypertension, John Reagan, Brown University, USA
- Mast cells as the cause of pulmonary vascular remodeling in pulmonary arterial hypertension, Wolfgang Kublar, Universitatsmedizin, Germany
- B-cell depletion with rituximab for the treatment of systemic sclerosis-associated pulmonary hypertension, Roham Zamanian, Stanford University, USA
- Emergency myelopoiesis contributes to immune cell exhaustion in pulmonary vascular remodeling, Andrew Bryan, University of Florida, USA
Moderated by Will Oldham, Mass General Brigham, USA.
Speakers & Moderators
Will Oldham (Moderator), Mass General Brigham, USA
Andrew Bryon, University of Florida, USA
Wolfgang Kubler, Universitatsmedizin, Germany
John Reagan, Brown University, USA
Mark Toshner, University of Cambridge, UK
Roham Zamanian, Stanford University, USA
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view